Accessibility Menu
Cochlear logo

Cochlear(OTC) CHEOY

Market Cap$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)+118%
5 Year-37%
1 Year-48%
1 Month+16%
$50.25
+2.74%
+1.34Today
Cochlear last closing stock price
MetricPriceDate
Last closeUSD 50.252026-09-03
Cochlear stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.13%USD 49.202026-08-27
1 month+16.43%USD 43.162026-08-04
3 month+43.96%USD 34.912026-06-05
Year to date-41.11%USD 85.332025-12-31
1 year-47.5%USD 95.722025-09-03
3 year-39.56%USD 83.142023-09-01
5 year-37.24%USD 80.072021-09-03
Since inception+118.4%USD 22.392009-10-19

Cochlear Financials at a Glance

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$4.69B

Net Income (TTM)

A$533.04M

EPS (TTM)

$0.73

P/E Ratio

66.76

Dividend

$1.45

Beta (Volatility)

0.70 (Low)

Price

$50.25

Volume

16,394

Open

$50.24

Previous Close

$50.25

Daily Range

$50.07 - $50.68

52-Week Range

$31.82 - $104.65

Estimated Earnings Date

Feb 11, 2026

CHEOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cochlear

Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world.

Products and Services
  • Cochlear implant systems for hearing restoration
  • Enhanced sound processor upgrades for improved performance
  • Bone conduction technology and complementary accessories
Growth Outlook
  • Strong demand for hearing solutions drives market expansion
  • Investment in R&D supports innovative product development
  • Global aging population increases potential customer base
Financial Highlights
  • Recent quarterly revenue of AUD 1.175 billion reflects solid performance
  • Trailing twelve months (TTM) net income margin of 6.31% indicates profitability
  • Dividend yield of 3.12% offers attractive returns for investors
Cochlear Limited is headquartered in Sydney, Australia, and has been a leader in the medical devices industry since its founding in 1981. The company focuses on enhancing the quality of life for individuals with hearing impairments through innovative technology. With a market capitalization of approximately USD 6.4 billion, Cochlear Limited is well-positioned for future growth, driven by increasing global demand for hearing solutions and a commitment to research and development. The company's financial performance demonstrates resilience, with a strong revenue base and a consistent dividend payout, making it an appealing option for potential investors interested in the healthcare sector.
AI Generated • Aug 27, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,400

CEO

Diggory William Howitt, MBA

Website

www.cochlear.com

Headquarters

Sydney, NSW 2109, AU

CHEOY Financials

Key Financial Metrics (TTM)

Gross Margin

70.53%

Operating Margin

12.89%

Net Income Margin

6.31%

Return on Equity

8.01%

Return on Capital

10.71%

Return on Assets

5.66%

Earnings Yield

1.50%

Dividend Yield

2.97%

Payout Ratio

1.91%

Stock Overview

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

130.80M

Volume

16.39K

Avg. Volume

51.63K

Financials (TTM)

Gross Profit

A$3.38B

Operating Income

A$823.88M

EBITDA

A$1.01B

Operating Cash Flow

A$615.69M

Capital Expenditure

-A$125.36M

Free Cash Flow

A$490.32M

Cash & ST Invst.

A$187.71M

Total Debt

A$212.71M

Cochlear Performance Analysis

Cochlear annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 1,315,608,22410.5%
20242024-06-30AUD 1,479,967,87812.5%
20252025-06-30AUD 1,525,689,0853.1%
20262026-06-30AUD 1,582,046,2783.7%
Cochlear sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-303.1%
Q42025-06-301.2%
Q22025-12-31-2.7%
Q42026-06-301.8%
Cochlear annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 1.53-3.7%
20242024-06-30AUD 1.7815.9%
20252025-06-30AUD 1.927.9%
20262026-06-30AUD 0.76-60.3%
Cochlear sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3023.8%
Q42025-06-30-10.3%
Q22025-12-31-13.2%
Q42026-06-30-109.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$1.18B

+3.3%

Gross Profit

A$801.05M

-6.9%

Gross Margin

68.17%

N/A

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.18M

N/A

Employees

5,400

N/A

Net Income

-A$14.40M

-108.7%

EBITDA

A$136.50M

-45.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$187.71M

-63.5%

Total Debt

A$212.71M

-12.7%

Accounts Receivable

A$559.23M

+14.0%

Inventory

A$491.33M

+25.5%

Long Term Debt

A$170.71M

-15.5%

Short Term Debt

A$42.00M

+1.0%

Return on Assets

5.66%

N/A

Return on Invested Capital

15.06%

N/A

Free Cash Flow

A$208.32M

+8.6%

Operating Cash Flow

A$243.80M

+5.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALBBYAlibaba Health Information Technology Limited
$7.87-1.69%
WILLFDemant A/S
$44.03+0.00%
WILYYDemant A/S
$22.70+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$1.11+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About CHEOY

What is the current price of Cochlear?

Cochlear is trading at $50.25 per share.

What is the 52-week range for Cochlear?

Over the past 52 weeks, Cochlear has traded between $31.82 and $104.65.

How much debt does Cochlear have?

As of the most recent reporting period, Cochlear reported total debt of A$147.36M.

How much cash does Cochlear have on hand?

Cochlear reported A$130.04M in cash and cash equivalents in its most recent financial results.

What is Cochlear’s dividend yield?

Cochlear currently has a dividend yield of 2.97%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services